Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, ...

University of Michigan researchers identified a gene program associated with extreme non-response to the cancer drug ...

For most patients, I typically initiate annual PSA screening at age 50. It’s important to know that primary care doctors perform most prostate cancer screenings.

More information: Dongyin He et al, Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy, Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2422267122 ...

It’s the latest in a series of advances targeting prostate cancer — the second most common cancer among men in the US, after skin cancer. “This is a significant discovery,” Lukas Kenner ...

Scientists have uncovered a promising way to fight prostate cancer by targeting a single enzyme, PI5P4Kα. This discovery offers new hope for patients, especially those whose cancer has become ...

Q: Turmeric and rosemary are two ingredients among 10 in an over-the-counter supplement I take. In lab studies, the supplement was found to inhibit the COX-2 enzyme and other inflammatory products ...

“Your PSA at the age of 45 can actually predict your risk for prostate cancer development down the road,” Dow said. Reference: Dow A. Clinical triad: Advances in cancer screening.

More information: Dongyin He et al, Fine structural design of 3βHSD1 inhibitors for prostate cancer therapy, Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2422267122 ...

Prostate cancer affects over 230,000 men each year, said KOAT health expert Dr. Abinash Achrekar, a University of New Mexico Hospital resident cardiologist, also known as Dr. Ash.

The enzyme, transmembrane serine protease 11B (TMPRSS11B) is described in a report published today in the journal Cell Reports. In addition to being found in squamous cell lung cancer and prostate ...